港股異動丨百威亞太(1876.HK)跌近6%創新低 肺炎疫情使業績承壓
格隆匯3月30日丨百威亞太(1876.HK)自上市以來股價走勢低迷,今日再次下跌5.72%盤中創19.7港元新低,現報19.94港元,暫成交2.39億港元,最新總市值2635.43億港元。在新冠肺炎的影響下,百威亞太預計,2020年前1-2月在中國市場的收入將同比減少約2.85億美元。並且2019年報顯示,公司業績及銷量皆下滑。主要是由於韓國市場競爭加劇和2019年下半年中國夜經濟的疲軟所致。小摩此前發佈報告稱,下調百威亞太盈測6%至12%,預計百威亞太今年銷售將倒退5.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.